Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
11-12
pubmed:dateCreated
1982-1-28
pubmed:abstractText
Asbestos-induced peritoneal mesothelioma 10-24 serially transplanted in Syrian golden hamsters was used to test responses to seven drugs as single agents. Compared to saline-treated controls, the average survival time increased 51%-85% with azactitidine, 42%-60% with aziridinylbenzoquinone, 43% with cisplatin, and 35%-45% with PCNU. No cures were achieved. Therapeutic responses were not observed with dactinomycin, dianhydroxyanthracenedione, or DTIC.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:issn
0361-5960
pubmed:author
pubmed:issnType
Print
pubmed:volume
65
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1113-5
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed-meshheading:6170430-Animals, pubmed-meshheading:6170430-Antineoplastic Agents, pubmed-meshheading:6170430-Azacitidine, pubmed-meshheading:6170430-Aziridines, pubmed-meshheading:6170430-Azirines, pubmed-meshheading:6170430-Benzoquinones, pubmed-meshheading:6170430-Cisplatin, pubmed-meshheading:6170430-Cricetinae, pubmed-meshheading:6170430-Cyclohexenes, pubmed-meshheading:6170430-Drug Administration Schedule, pubmed-meshheading:6170430-Drug Evaluation, Preclinical, pubmed-meshheading:6170430-Male, pubmed-meshheading:6170430-Mesocricetus, pubmed-meshheading:6170430-Mesothelioma, pubmed-meshheading:6170430-Mustard Compounds, pubmed-meshheading:6170430-Neoplasm Transplantation, pubmed-meshheading:6170430-Neoplasms, Experimental, pubmed-meshheading:6170430-Nitrosourea Compounds, pubmed-meshheading:6170430-Time Factors
pubmed:articleTitle
Chemotherapeutic trials with hamster mesothelioma 10-24: responses to azacitidine, aziridinylbenzoquinone, cisplatin, and PCNU.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't